TY - JOUR
T1 - Trends in low vision service utilisation
T2 - A retrospective study based on general population healthcare claims
AU - Stolwijk, Miriam L.
AU - van Nispen, Ruth M. A.
AU - Verburg, Ilona W. M.
AU - van Gerwen, Lieke
AU - van de Brug, Tim
AU - van Rens, Ger H. M. B.
N1 - Funding Information:
The authors would like to thank Vektis CV and the Dutch Health insurers collaboration for allowing us to use the claims database and for assisting and sharing their knowledge regarding health claims data.
Publisher Copyright:
© 2022 The Authors. Ophthalmic and Physiological Optics published by John Wiley & Sons Ltd on behalf of College of Optometrists.
PY - 2022/7/1
Y1 - 2022/7/1
N2 - Purpose: To identify parameters associated with the downward trend in the uptake of Low Vision Services (LVS) in the Netherlands. Methods: A retrospective cohort study was conducted based on a Dutch national health insurance claims database (Vektis CV) of all adults (≥18 years) who received LVS from 2015 until 2018. Descriptive statistics were used to assess socio-demographic, clinical and contextual characteristics and other healthcare utilisation of the study population. General estimating equations trends in characteristics and healthcare utilisation were determined over time. Results: A total of 49,726 unique patients received LVS, but between 2015 and 2018, the number of patients decreased by 15%. The majority was aged 65 years or older (53%), female (54%), had a middle (38%) or low (24%) socio-economic status and lived in urban areas (68%). Between 2015–2018, significant downward trends were found for treatment with intravitreal injections and lens-related diseases for LVS patients. For physical comorbidity, utilisation of ophthalmic care, low vision aids and occupational therapy, a significant upward trend was found over time. Conclusion: The decrease of Dutch LVS patients by 15% between 2015 and 2018 might be explained by a reduced distribution of patients treated with intravitreal injections and patients with lens-related diseases within the LVS. Compared to 2015, patients were more likely to have physical comorbidity, to see an ophthalmologist and to use low vision aids and occupational therapy in 2016, 2017 and 2018. This might indicate enhanced access to LVS when treated by ophthalmologists or within other medical specialties, or the opposite, i.e., less access when not treated within one of these medical specialties. Future research is needed to examine differences in patterns between LVS users and non-users further.
AB - Purpose: To identify parameters associated with the downward trend in the uptake of Low Vision Services (LVS) in the Netherlands. Methods: A retrospective cohort study was conducted based on a Dutch national health insurance claims database (Vektis CV) of all adults (≥18 years) who received LVS from 2015 until 2018. Descriptive statistics were used to assess socio-demographic, clinical and contextual characteristics and other healthcare utilisation of the study population. General estimating equations trends in characteristics and healthcare utilisation were determined over time. Results: A total of 49,726 unique patients received LVS, but between 2015 and 2018, the number of patients decreased by 15%. The majority was aged 65 years or older (53%), female (54%), had a middle (38%) or low (24%) socio-economic status and lived in urban areas (68%). Between 2015–2018, significant downward trends were found for treatment with intravitreal injections and lens-related diseases for LVS patients. For physical comorbidity, utilisation of ophthalmic care, low vision aids and occupational therapy, a significant upward trend was found over time. Conclusion: The decrease of Dutch LVS patients by 15% between 2015 and 2018 might be explained by a reduced distribution of patients treated with intravitreal injections and patients with lens-related diseases within the LVS. Compared to 2015, patients were more likely to have physical comorbidity, to see an ophthalmologist and to use low vision aids and occupational therapy in 2016, 2017 and 2018. This might indicate enhanced access to LVS when treated by ophthalmologists or within other medical specialties, or the opposite, i.e., less access when not treated within one of these medical specialties. Future research is needed to examine differences in patterns between LVS users and non-users further.
KW - healthcare claims
KW - low vision
KW - low vision services
KW - service utilisation
KW - visual impairment
UR - http://www.scopus.com/inward/record.url?scp=85131648869&partnerID=8YFLogxK
U2 - 10.1111/opo.12982
DO - 10.1111/opo.12982
M3 - Article
C2 - 35661209
SN - 0275-5408
VL - 42
SP - 828
EP - 838
JO - Ophthalmic and Physiological Optics
JF - Ophthalmic and Physiological Optics
IS - 4
ER -